Visit and discuss your formulation and drug delivery challenges with our subject matter experts at the booth #26.


The 11th Global Drug Delivery & Formulation (DDF) Summit will bring together the pharmaceutical development community in Berlin, Germany.  At this high-level scientific summit scientists and technologists representing big pharma, subject matter experts, solution providers and academia will meet and discuss exciting future innovations.  Lonza scientists will be present and look forward to discussing how we can assist in advancing your promising molecules.

For registration click here.

DavidLyon_adjusted.jpg

 

Join David Lyon, PhD, Sr. Fellow - Research at Lonza Pharma & Biotech  

on Monday, 9 March 2020 at 2:30 pm

and learn more about

"An Integrated Approach to Rapidly Advancing Poorly Bioavailable Compounds to the Clinic”.

 

- Integration of active pharmaceutical ingredient synthesis and drug product development activities
- Technology selection for poorly soluble molecules based on physical-chemical properties
- Tools and approaches for the rapid advancement of poorly soluble compounds to the clinic
- Representative case studies

Currently it is estimated that over 70% of the compounds in development have dissolution rate and/or solubility issues that require enabling technologies to achieve adequate oral absorption.  Furthermore, a significant fraction of these assets is held by small-to-medium sized biotechnology companies that often lack resources and “bricks and mortar” to independently drive the compounds to the clinic and beyond. 

In this talk we will discuss an integrated service offering specifically developed to rapidly advance poorly soluble assets to the clinic.  This flexible service offering utilizes in silico predictions and bulk sparing laboratory tests to develop clinically ready formulations with a line of sight to commercial production

Can't attend the show? Join our next webinar register here

"In Webinar_Feb27_2020_Stewart_LinkedIn_1200-627_final (2).jpgVitro Test Methodologies for Characterizing Bioavailability Enhancing Formulations"
Presented by Aaron Stewart, Associate Principal Scientist at Lonza Pharma & Biotech

27 February 2020 • 8 a.m. PST / 11 a.m. EST

 

 

Learn more about our SimpliFiH Solutions™ integrated first-in-human service offering click here.

 


Use the form below to schedule a meeting with Lonza team 

By submitting your data through this form, you confirm that you are above the age of 18, that you have read and understood the Privacy Policy, and that you agree to the collection, use and processing of your Personal Information by Lonza in accordance with said policy.